Data as of Nov 21
| +0.04 / +0.80%|
The 2 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 9.50, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +88.12% increase from the last price of 5.05.
The current consensus among 2 polled investment analysts is to Buy stock in Sinovac Biotech Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.